German researchers at Heidelberg University Hospital have developed what they called "the first blood analysis" to detect breast cancer, describing their discovery as a "milestone" in diagnosing the disease.

While there is no analysis to determine if a woman is sick or healthy, "taking a fluid sample" is a non-surgical procedure that can determine whether "there is no analysis," Christophe Zon, the hospital's medical director, said during a presentation in Düsseldorf. From disease »or not.

He added that the blood analysis, which will be marketed this year, does not aim to compete with traditional radiography, ultrasound or magnetic resonance imaging (MTR).

"These are completely different ways to detect the disease," he said.

The new examination is based mainly on taking a blood sample for analysis.

In a written statement, Zun and the team say that if breast cancer is detected early, there is a "95 percent chance" of treatment.

German researchers at Heidelberg University Hospital have developed what they called "the first blood analysis" to detect breast cancer, describing their discovery as a "milestone" in diagnosing the disease.

While there is no analysis to determine if a woman is sick or healthy, "taking a fluid sample" is a non-surgical procedure that can determine whether "there is no analysis," Christophe Zon, the hospital's medical director, said during a presentation in Düsseldorf. From disease »or not.

He added that the blood analysis, which will be marketed this year, does not aim to compete with traditional radiography, ultrasound or magnetic resonance imaging (MTR).

"These are completely different ways to detect the disease," he said.

The new examination is based mainly on taking a blood sample for analysis.

In a written statement, Zun and the team say that if breast cancer is detected early, there is a "95 percent chance" of treatment.

German researchers at Heidelberg University Hospital have developed what they called "the first blood analysis" to detect breast cancer, describing their discovery as a "milestone" in diagnosing the disease.

While there is no analysis to determine if a woman is sick or healthy, "taking a fluid sample" is a non-surgical procedure that can determine whether "there is no analysis," Christophe Zon, the hospital's medical director, said during a presentation in Düsseldorf. From disease »or not.

He added that the blood analysis, which will be marketed this year, does not aim to compete with traditional radiography, ultrasound or magnetic resonance imaging (MTR).

"These are completely different ways to detect the disease," he said.

The new examination is based mainly on taking a blood sample for analysis.

In a written statement, Zun and the team say that if breast cancer is detected early, there is a "95 percent chance" of treatment.

- See more at: http://www.alkhaleej.ae/alkhaleej/page/4f836b44-fd2a-43c2-885f-1ef9c50c349d#sthash.0K7RpK80.dpuf